Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × FED × Lymphoid × Clear all

Phase

Phase 2 4 Phase NA 3 Phase EARLY_PHASE1 1 Phase 4 1 Phase 1 1

Status

Sponsor Class

INDUSTRY 890 OTHER 826 NIH 233 NETWORK 19 OTHER_GOV 10 UNKNOWN 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3 Gastrointestinal 3 Breast 3 Gynecologic 2 Genitourinary 2 Other hematologic neoplasm 1 Lymphoid 1 CNS 1

Conditions

Lymphoproliferative Disorders 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hematologic Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00028418 2015-03-25

Clofarabine in Chronic Lymphocytic Leukemia

FDA Office of Orphan Products Development

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡